KIDS — Orthopediatrics Income Statement
0.000.00%
- $534.87m
- $539.15m
- $204.73m
- 67
- 47
- 32
- 46
Annual income statement for Orthopediatrics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 71.1 | 98 | 122 | 149 | 205 |
Cost of Revenue | |||||
Gross Profit | 55 | 73.4 | 90.7 | 111 | 149 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 97.8 | 116 | 148 | 175 | 243 |
Operating Profit | -26.8 | -18 | -25.4 | -26.8 | -38.2 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -33.7 | -17.4 | -3.69 | -21.3 | -41.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | -32.9 | -16.3 | 1.26 | -21 | -37.8 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -32.9 | -16.3 | 1.26 | -21 | -37.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -32.9 | -16.3 | 1.26 | -21 | -37.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.56 | -0.828 | 0.184 | -0.897 | -1.39 |